维普期刊资源整合服务平台（V6.5）

49篇 您的检索式：作者名="Shaw EL"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Morphological appearance of the healing corneal endothelium 显示文摘	Rao SN Shaw EL Arthur E	1978	Arch Ophthalmol1978，96，10：	2
2	Clinical activity of the oral ALK i nhibitor,PF-02341066, in ALK-positive patients with non- small cell lung cancer (NSCLC) 显示文摘	Bang Y Kwak EL Shaw AT	2010	J Clin Oncol2010，27，15：	1
3	Clinical activity of the oral ALK inhibitor PF-02341066 in ALK-positive patients with non-small cell lung cancer(NSCLC)显示文摘	Bang Y Kwak EL Shaw AT	2010	J Clin Oncol(Meeting Abstracts)2010，28，18：	1
4	Keratectasia after laser in situ keratomileusis (LASIK):Evaluation of the calculated residual stromal bed thickness显示文摘	Ou R J Shaw EL Glasgow BJ	2002	Am J Ophthalmol2002，134，5：	1
5	Clinical activity of the oral ALK inhibitor PF-02341066 in ALK-positive patients with non-small cell lung cancer (NSCLC) 显示文摘	Bang Y Kwak EL Shaw AT	2010	J Clin Oncol2010，28，18：	1
6	Clinical activity of the oral ALK inhibitor PF-02341066 in ALK-positive patients with non-small cell lung cancer(NSCLC)显示文摘	Bang Y Kwak EL Shaw AT	2010	J Clin Oncol(Meeting Abstracts)2010，28，18：	1
7	Clinical activity of the oral ALK inhibitor,PF-02341066,in ALK-positive patients with non-small eel]lung cancer显示文摘	Bang Y Kwak EL Shaw A	2010	J Clin Oncol2010，28，18：	1
8	Keratectasia after laser in situ keratomileusis(LASIK):evaluation of the caculated residual stromal bed thickness显示文摘	Ou RJ Shaw EL Glasgow BJ	2002	Am J Ophthalmol2002，134，6：	1
9	Risk factors forneural tube defects : associations between uncoupling pro-tein 2 polymorptfisms and spina显示文摘	Volcik K A Shaw G M Zhu H el al	2003	Birth Defects ResA Clin Mol Teratol2003，67，3：	1
10	Clinical activity of the oral ALK inhibitor, PF-02341066, in ALK-positive patients with non-small cell lung cancer(NSCLC)显示文摘	Bang Y Kwak EL Shaw AT	2010	J Clin Oncol2010，28，18：	1
11	Keratectasia after laser in situ keratomileusis(LASIK) :Evaluation of the calculated residual stromal bed thickness 显示文摘	Ou R J Shaw EL Glasgow BJ	2002	Am J Ophthalmol2002，134，5：	1
12	Management of increased vitreous pressureduring penetrating keratoplasty using pars plana anterior vitre-ous aspiration显示文摘	Gross RH Shaw EL	2001	Cornea2001，20，3：	1
13	Operative start times and complications after kidney transplantation 显示文摘	Shaw TM Lonze BE Feyssa EL	2012	Clin Transplant2012，26，3：	1
14	Keratoectasia after laser in situ keratomileusis(LASIK):evaluation of the calculated residual stromal bed thickness显示文摘	Ou RJ Shaw EL Glasgow BJ		0，，05：	1
15	Hyperphosphorylated neumfilament NF-H is a serum biomarker of axonal injury显示文摘	Shaw G 'fang C Ellis 1L el al	2005	Biochem Biophys Res Commun2005，336，4：	1
16	Atgl6L1 is required for autophagy in intestinal epithelial cells and protection of mice from Salmonella infection 显示文摘	Conway KL Kuballa P Song JH Patel KK Castoreno AB Yilmaz OH Jijon HB Zhang M Aldrich LN Villa- blanca El Peloquin JM Goel G Lee IA Mizoguchi E Shi HN Bhan A_K Shaw SY Schreiber SL Virgin HW Shamji AF Stappenbeck TS Reinecker HC Xavier RJ	2013	Gastroenterology2013，145，6：	1
17	T cells engineered with a chimeric antigen receptor ( CAR ) targeting CD19 ( CTL019 ) have long term persistence and induce durable remissions in children with relapsed, refractory ALL 显示文摘	Grupp SA Maude SL Shaw P et el	2014	Blood ( ASH annual meeting Abstracts)2014，124，21：	1
18	Mental disorder and clinical care in people convticted of homicide: national chinicial survey显示文摘	Shaw J Appleby L Amos T et el	1999	BMJ1999，318，7193：	1
19	Clinical activity of the oral ALK inhibitor PF-02341066 in ALK-positive patients with non-small cell lung cancer (NSCLC)显示文摘	Bang Y Kwak EL Shaw AT		0，，1：	1
20	Clinical activity of the oral ALK inhibitor,PF-02341066,in ALK-positive patients with non-small cell lung cancer (NSCLC)显示文摘	Bang Y Kwak EL Shaw AT	2010	J Clin Oncol(Meeting Abstracts)2010，28，18：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示